Moreover, it inhibited the cancer growth in different in vivo murine models, e.g., a U251-luc intracranially orthotopic xenograft, an EGFR knockdown U251 subcutaneous xenograft, and a patient-derived xenograft model [105]. This evidence concerns the gene EGFR and cancer.